Dr. Hulda

[Guest guest]

On November 2, 1999, this letter was first posted to the e-mail resource 'cures for cancer@...'.

www.jsr1936.com The Cure for Cancer? jsr1936@...

Dear citizens of the world concerned about cancer,

Could anyone e-mail to me the address or e-mail address of Dr. Hulda and her attorney?

I would like to inform them that the National Cancer Institute has known about a possible cure for cancer for the past two decades, but has thus far chosen to do absolutely nothing about it (as far as I can determine).

Harold Varmus, M.D., Director of the National Institutes of Health can correct me if I am mistaken.

Thiazolidine-4-carboxylic " could represent the first non-cytotoxic anticancer agent which has the plasma membrane as target. "

This conclusion is found in 'Proceedings of the American Association for Cancer Research', March, 1979, Volume 20, page 17.

The research was " Supported by the U.S. National Cancer Institute, contract NO1-CM-53792. "

A subsequent clinical trial in Spain revealed these results when Thiazolidine-4-carboxylic acid was administered to human beings; the report is found in 'The Lancet', January 12, 1980 issue, pages 68-70 under the title, 'TREATMENT OF CANCER BY AN INDUCER OF REVERSE TRANSFORMATION' (the bold face emphasis is mine):

" Thiazolidine-4-carboxylic acid (thioproline, 'norgamem' - A name derived from its capacity to restore normal organisation of membranes.) a compound found to act on the cell membranes of tumour cells, causing reverse transformation to normal cells was investigated in patients with advanced cancer. Responses were obtained at several dose levels mainly in epidermoid carcinoma of the head and neck with pulmonary metastases. Histological studies showed involution and transformation into low-grade malignancies and disappearance of evidence of cancer. " page 68

" No toxicity was observed and all regimens were equally well tolerated. Most patients had a feeling of well-being and there was no nausea, vomiting, myelo-depression, or central-nervous-system symptoms. No changes in pulmonary, cardiac, hepatic, or renal functions were found..... " page 69

" Thioproline seemed to be completely nontoxic over a wide range of doses, and had a considerable antitumour effect in epidermoid carcinoma of the head and neck. Definite signs of activity were observed in epidermoid carcinoma of other regions and in other solid tumours, such as breast, renal, ovary, thyroid, and parotid cancer. " page 69

" Reverse transformation seemed to affect only tumour cells, since no effect was observed in the normal skin, mucosae, or other epithelial tissues. The selective character of this action explained the absence of toxicity of thioproline treatment. " page 70

Since November, 1997, I have been imploring Federal Health Officials in the Washington, D.C. area to conduct a cancer clinical trial which would utilize 'mega-doses' of Thiazolidine-4-carboxylic acid and vitamin C and 'above-average' amounts of magnesium, zinc and manganese; see the picture on the last page of www.jsr1936.com.

Thus far I have not met with any success. In fact, I have never received a definitive response from anyone.

Yours truly,

S. , P.O. Box H, Hobart, Indiana 46342, (219) 763-1933

e-mail copy to Harold Varmus, M.D., Director, National Institutes of Health, Bethesda, land,

execsec1@..., (301) 496-2433

Mail copies of this letter to -

President Clinton, The White House, Washington, D.C.

Donna E. Shalala, Ph.D., Secretary of Health and Human Services, Washington, D.C.

Professor V. Schally, Veterans Affairs Medical Center, New Orleans, Louisiana

F. Cathcart, M.D., 'Orthomolecular Medicine', Los Altos, California

Mr. Jon Huntsman and M. Prescott, M.D., Executive Director,

'Huntsman Cancer Institute', Salt Lake City, Utah

e-mail copies to various persons